Stockreport

Allogene Therapeutics Teases April ALPHA3 Futility Data, Details Autoimmune CAR-T Program at TD Cowen [Yahoo! Finance]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF based on MRD clearance in 24 patients , with a prespecified bar of an absolute 25–30% MRD clearance improvement for cema-cel versus observation; the randomized ~220-pati [Read more]